Do You Qualify for Dojolvi (Triheptanoin) Coverage by Cigna in Illinois? Complete Decision Tree & Appeals Guide
Answer Box: Your Path to Dojolvi Coverage
To qualify for Dojolvi (triheptanoin) coverage by Cigna in Illinois, you need molecular confirmation of long-chain fatty acid oxidation disorder (LC-FAOD) and must discontinue all MCT products first. Submit prior authorization through Accredo specialty pharmacy via ExpressPAth or CoverMyMeds. If denied, file internal appeals within 180 days, then external review with Illinois Department of Insurance within 4 months. Start today by confirming your genetic test results and gathering treatment history documentation.
Table of Contents
- How to Use This Decision Tree
- Eligibility Triage: Do You Qualify?
- If "Likely Eligible" - Your Approval Checklist
- If "Possibly Eligible" - Tests to Request
- If "Not Yet" - Alternative Options
- If Denied - Illinois Appeal Path
- Coverage Requirements at a Glance
- Common Denial Reasons & How to Fix Them
- Frequently Asked Questions
- Sources & Further Reading
How to Use This Decision Tree
This guide helps patients and clinicians navigate Cigna's specific requirements for Dojolvi (triheptanoin) in Illinois. Start with the eligibility triage below to determine your approval likelihood, then follow the corresponding section for next steps.
Note: Dojolvi costs approximately $5,857–$6,365 per 500-mL bottle and is dispensed exclusively through Accredo specialty pharmacy for Cigna members.
Key Illinois advantage: The state provides robust external review rights through the Illinois Department of Insurance, with independent physician reviewers who can overturn Cigna denials within 45 days.
Eligibility Triage: Do You Qualify?
✅ Likely Eligible
- Molecular confirmation: Genetic testing shows pathogenic variants in LC-FAOD genes (ACADVL, HADHA, HADHB, CPT2, or SLC25A20)
- Diagnosis codes: ICD-10 E71.310–E71.318 series documented
- MCT discontinuation: All medium-chain triglyceride products stopped for ≥90 days OR documented intolerance/contraindication
- Specialist involvement: Prescribed by or in consultation with metabolic disorder specialist
- Treatment history: Evidence of symptomatic episodes despite standard dietary management
🟡 Possibly Eligible
- Biochemical confirmation only: Elevated acylcarnitines consistent with LC-FAOD but genetic testing pending
- Recent MCT trial: Currently on MCT oil with <90 days of documented failure
- Missing specialist: Primary care or general pediatrician prescribing without metabolic consultation
- Incomplete documentation: Some clinical evidence but missing key requirements above
❌ Not Yet Eligible
- No molecular confirmation: Genetic testing not performed or negative
- Active MCT use: Currently taking MCT products without documented failure
- Wrong diagnosis: Confirmed medium-chain or short-chain fatty acid oxidation disorder
- No clinical evidence: Asymptomatic or symptoms explained by other conditions
If "Likely Eligible" - Your Approval Checklist
Step 1: Gather Required Documentation
- Genetic test results showing pathogenic LC-FAOD variants
- Medical records documenting metabolic episodes (hypoglycemia, rhabdomyolysis, cardiomyopathy)
- MCT discontinuation evidence (pharmacy records, clinical notes)
- Specialist consultation notes or referral
- Current insurance card and Cigna member ID
Step 2: Submit Prior Authorization
Primary method: ExpressPAth portal (prescriber registration required)
Alternative methods:
- CoverMyMeds platform
- MyAccredoPatients.com
Timeline: Cigna responds within 72 hours for standard requests, 24 hours for urgent cases.
Step 3: Track Your Request
Monitor status via Express Scripts member portal under "Prior Authorizations" or call Accredo patient services for updates.
If "Possibly Eligible" - Tests to Request
Missing Genetic Confirmation
Request: Fatty acid oxidation disorders gene panel through:
- University of Illinois Chicago Metabolic Center: (312) 996-6189
- Ann & Robert H. Lurie Children's Hospital: (312) 227-6550
- Invitae sponsored testing program (no charge for LC-FAOD testing)
Incomplete MCT Trial Documentation
Track for 90 days:
- Symptom frequency and severity
- Exercise tolerance
- Laboratory values (CK, transaminases)
- Any adverse effects from MCT oil
Timeline to reapply: 3-4 months after completing documentation requirements.
If "Not Yet" - Alternative Options
While Pursuing Genetic Testing
- Emergency protocols: Work with metabolic specialist on sick-day management
- Dietary optimization: Maximize frequent feeding, avoid fasting >8-12 hours
- Carnitine supplementation: If recommended by specialist
- Insurance exception request: Submit with detailed medical necessity letter explaining diagnostic workup in progress
Cost Assistance Options
- Ultragenyx patient support: Contact manufacturer for financial assistance programs
- Foundation grants: Research rare disease foundations offering emergency medication funding
- State programs: Illinois may have specialty drug assistance for qualifying patients
If Denied - Illinois Appeal Path
Level 1: Internal Appeal (First Step)
Deadline: 180 days from denial notice Submit to: Express Scripts/Cigna appeals department Required documents:
- Copy of denial letter
- Updated clinical notes
- Genetic test results
- Medical necessity letter from specialist
Timeline: 30 days for standard appeals, 15 days for expedited
Level 2: Peer-to-Peer Review
Request: Phone consultation between Cigna medical director and prescribing specialist Advantage: Direct physician-to-physician discussion of clinical rationale Timeline: Usually scheduled within 5-10 business days
Level 3: External Review (Illinois Specific)
Deadline: 4 months from final internal denial Submit to: Illinois Department of Insurance Process: Independent physician reviewer evaluates case Timeline: Up to 45 days for standard review, 72 hours for expedited Cost: Free to patients Decision: Binding on Cigna if overturned
Illinois advantage: External review decisions in Illinois have strong legal backing and high overturn rates for rare disease denials with proper documentation.
Coverage Requirements at a Glance
| Requirement | What It Means | Where to Find It | Source |
|---|---|---|---|
| Prior Authorization | Required for all Dojolvi prescriptions | ExpressPAth portal | Cigna Policy |
| Molecular Confirmation | Genetic testing with pathogenic variants | Lab report from CLIA-certified facility | Cigna PA Criteria |
| Step Therapy | MCT oil trial required first | Pharmacy records or clinical notes | Prime Therapeutics |
| Specialist Involvement | Metabolic disorder physician required | Referral or consultation notes | Cigna Coverage Policy |
| Quantity Limits | Based on weight and caloric needs | Dosing calculations in PA request | FDA Label |
Common Denial Reasons & How to Fix Them
| Denial Reason | How to Overturn | Required Documents |
|---|---|---|
| "Molecular confirmation missing" | Submit complete genetic test results | Lab report with pathogenic variant identification |
| "Concurrent MCT use" | Document MCT discontinuation | Pharmacy records showing stopped fills, clinical notes |
| "Lack of specialist involvement" | Obtain metabolic consultation | Referral letter or consultation report |
| "Not medically necessary" | Provide clinical evidence of metabolic episodes | Hospital records, lab values during decompensation |
| "Quantity exceeds limits" | Justify dosing based on weight/caloric needs | Nutritionist calculations, growth charts |
Frequently Asked Questions
Q: How long does Cigna prior authorization take for Dojolvi in Illinois? A: Standard requests receive responses within 72 hours; urgent requests within 24 hours. Complex cases requiring additional review may take up to 15 business days.
Q: What if Dojolvi is non-formulary on my Cigna plan? A: Request a formulary exception with medical necessity documentation. Cigna must review based on clinical need even for non-formulary medications.
Q: Can I request an expedited appeal in Illinois? A: Yes, if treatment delay would seriously jeopardize your health. Both internal appeals and external reviews offer expedited pathways with shortened timelines.
Q: Does step therapy apply if I've tried MCT oil outside Illinois? A: Yes, step therapy requirements follow the patient, not the state. Document your previous MCT trial with medical records from any state.
Q: What happens if I miss the 4-month external review deadline in Illinois? A: The deadline is strict, but you may file a complaint with the Illinois Department of Insurance for exceptional circumstances or if Cigna didn't properly inform you of appeal rights.
Q: How successful are Dojolvi appeals with Cigna? A: Recent data shows approximately 50% success rate for LC-FAOD medication appeals when complete documentation is provided, particularly with specialist support.
When navigating complex prior authorization requirements like those for Dojolvi, having expert support can make the difference between approval and denial. Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into successful appeals by analyzing denial letters, identifying specific coverage criteria, and crafting evidence-backed rebuttals that align with each payer's requirements. Their platform specializes in complex specialty medications and understands the unique documentation needs for rare disease treatments like LC-FAOD therapies.
From our advocates: "We've seen Dojolvi cases where initial denials cited 'experimental' status, but appeals succeeded by referencing FDA approval under accelerated pathway and emphasizing the lack of therapeutic alternatives for LC-FAOD. The key was matching the clinical evidence to Cigna's specific medical necessity criteria rather than general arguments about rare disease needs."
Sources & Further Reading
- Cigna Triheptanoin Coverage Policy (PDF)
- Illinois Department of Insurance External Review
- Express Scripts Prior Authorization FAQ
- Accredo Specialty Pharmacy
- FDA Dojolvi Label and Approval
- Invitae LC-FAOD Genetic Testing
- Illinois Attorney General Health Care Bureau
Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies vary by plan and change frequently. Always verify current requirements with your insurance provider and consult healthcare professionals for medical decisions. For additional assistance with insurance appeals in Illinois, contact the Illinois Department of Insurance Consumer Assistance at (877) 527-9431.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.